366 related articles for article (PubMed ID: 28797204)
61. Diagnostics for neonatal sepsis: current approaches and future directions.
Iroh Tam PY; Bendel CM
Pediatr Res; 2017 Oct; 82(4):574-583. PubMed ID: 28574980
[TBL] [Abstract][Full Text] [Related]
62. Molecular imprinting based electrochemical biosensor for identification of serum amyloid A (SAA), a neonatal sepsis biomarker.
Balayan S; Chauhan N; Chandra R; Jain U
Int J Biol Macromol; 2022 Jan; 195():589-597. PubMed ID: 34920065
[TBL] [Abstract][Full Text] [Related]
63. Accuracy of serum procalcitonin for the diagnosis of sepsis in neonates and children with systemic inflammatory syndrome: a meta-analysis.
Pontrelli G; De Crescenzo F; Buzzetti R; Jenkner A; Balduzzi S; Calò Carducci F; Amodio D; De Luca M; Chiurchiù S; Davies EH; Copponi G; Simonetti A; Ferretti E; Di Franco V; Rasi V; Della Corte M; Gramatica L; Ciabattini M; Livadiotti S; Rossi P
BMC Infect Dis; 2017 Apr; 17(1):302. PubMed ID: 28438138
[TBL] [Abstract][Full Text] [Related]
64. Reduction in the use of diagnostic tests in infants with risk factors for early-onset neonatal sepsis does not delay antibiotic treatment.
Duvoisin G; Fischer C; Maucort-Boulch D; Giannoni E
Swiss Med Wkly; 2014; 144():w13981. PubMed ID: 24964177
[TBL] [Abstract][Full Text] [Related]
65. The utility of maternal mean platelet volume levels for early onset neonatal sepsis prediction of term infants.
Cekmez Y; Dizdar Güleçoğlu M; Özcan C; Karadeniz L; Kıran G
Ginekol Pol; 2017; 88(6):312-314. PubMed ID: 28727130
[TBL] [Abstract][Full Text] [Related]
66. Neutrophil CD64 combined with PCT, CRP and WBC improves the sensitivity for the early diagnosis of neonatal sepsis.
Yang AP; Liu J; Yue LH; Wang HQ; Yang WJ; Yang GH
Clin Chem Lab Med; 2016 Feb; 54(2):345-51. PubMed ID: 26351925
[TBL] [Abstract][Full Text] [Related]
67. Biomarkers for late-onset neonatal sepsis: cytokines and beyond.
Ng PC; Lam HS
Clin Perinatol; 2010 Sep; 37(3):599-610. PubMed ID: 20813273
[TBL] [Abstract][Full Text] [Related]
68. miRNA-23b as a biomarker of culture-positive neonatal sepsis.
Fatmi A; Rebiahi SA; Chabni N; Zerrouki H; Azzaoui H; Elhabiri Y; Benmansour S; Ibáñez-Cabellos JS; Smahi MC; Aribi M; García-Giménez JL; Pallardó FV
Mol Med; 2020 Oct; 26(1):94. PubMed ID: 33032520
[TBL] [Abstract][Full Text] [Related]
69. Diagnostic markers of infection in neonates.
Ng PC
Arch Dis Child Fetal Neonatal Ed; 2004 May; 89(3):F229-35. PubMed ID: 15102726
[TBL] [Abstract][Full Text] [Related]
70. [Interleukin-6, procalcitonin, C-reactive protein and the immature to total neutrophil ratio (I/T) in the diagnosis of early-onset sepsis in low birth weight neonates].
Janota J; Stranák Z; Bĕlohlávková S
Ceska Gynekol; 2000 Dec; 65 Suppl 1():29-33. PubMed ID: 11394228
[TBL] [Abstract][Full Text] [Related]
71. Diagnosis of neonatal sepsis: the past, present and future.
Celik IH; Hanna M; Canpolat FE; Mohan Pammi
Pediatr Res; 2022 Jan; 91(2):337-350. PubMed ID: 34728808
[TBL] [Abstract][Full Text] [Related]
72. Biomarkers for the Diagnosis of Neonatal Sepsis.
Cantey JB; Lee JH
Clin Perinatol; 2021 Jun; 48(2):215-227. PubMed ID: 34030810
[TBL] [Abstract][Full Text] [Related]
73. Impact of neonatal early-onset sepsis calculator on antibiotic use within two tertiary healthcare centers.
Warren S; Garcia M; Hankins C
J Perinatol; 2017 Apr; 37(4):394-397. PubMed ID: 28005063
[TBL] [Abstract][Full Text] [Related]
74. Comparison of serum amyloid A concentrations with those of C-reactive protein and procalcitonin in diagnosis and follow-up of neonatal sepsis in premature infants.
Cetinkaya M; Ozkan H; Köksal N; Celebi S; Hacimustafaoğlu M
J Perinatol; 2009 Mar; 29(3):225-31. PubMed ID: 19078972
[TBL] [Abstract][Full Text] [Related]
75. Serum Interleukin-33 as a Biomarker in Predicting Neonatal Sepsis in Premature Infants.
Halil H; Tayman C; Buyuktiryaki M; Okur N; Cakır U; Serkant U
Comb Chem High Throughput Screen; 2018; 21(7):510-515. PubMed ID: 30207217
[TBL] [Abstract][Full Text] [Related]
76. Evaluation of natural killer cells as diagnostic markers of early onset neonatal sepsis: comparison with C-reactive protein and interleukin-8.
el-Sameea ER; Metwally SS; Mashhour E; el-Bendary A; Hassan AM; el-Sharkawy H; el-Shennawy FA
Egypt J Immunol; 2004; 11(1):91-102. PubMed ID: 15724391
[TBL] [Abstract][Full Text] [Related]
77. Variation in Sepsis Evaluation Across a National Network of Nurseries.
Mukhopadhyay S; Taylor JA; Von Kohorn I; Flaherman V; Burgos AE; Phillipi CA; Dhepyasuwan N; King E; Dhudasia M; Puopolo KM
Pediatrics; 2017 Mar; 139(3):. PubMed ID: 28179485
[TBL] [Abstract][Full Text] [Related]
78. Use of procalcitonin-guided decision-making to shorten antibiotic therapy in suspected neonatal early-onset sepsis: prospective randomized intervention trial.
Stocker M; Fontana M; El Helou S; Wegscheider K; Berger TM
Neonatology; 2010; 97(2):165-74. PubMed ID: 19776651
[TBL] [Abstract][Full Text] [Related]
79. Diagnostic utility of biomarkers for neonatal sepsis--a systematic review.
Hedegaard SS; Wisborg K; Hvas AM
Infect Dis (Lond); 2015 Mar; 47(3):117-24. PubMed ID: 25522182
[TBL] [Abstract][Full Text] [Related]
80. Presepsin for the detection of early-onset sepsis in preterm newborns.
Montaldo P; Rosso R; Santantonio A; Chello G; Giliberti P
Pediatr Res; 2017 Feb; 81(2):329-334. PubMed ID: 27925621
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
